| Fitch Affirms DaVita Inc.'s IDR at 'BB-'; Outlook Stable - MarketWatch (press release) |
|
|
MarketWatch (press release)Medicare currently reimburses ESRD treatment providers for these drugs on a per unit basis, outside of the bundle. Fitch notes that ESAs account for ... read more |